GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Works Technologies AB (XSAT:BIOWKS) » Definitions » Forward Dividend Yield %

Bio-Works Technologies AB (XSAT:BIOWKS) Forward Dividend Yield % : 0.00% (As of May. 22, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Works Technologies AB Forward Dividend Yield %?

As of today (2025-05-22), the Forward Annual Dividend Yield of Bio-Works Technologies AB is 0.00%.

As of today (2025-05-22), the Trailing Annual Dividend Yield of Bio-Works Technologies AB is 0.00%.

XSAT:BIOWKS's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.445
* Ranked among companies with meaningful Forward Dividend Yield % only.

Bio-Works Technologies AB's Dividends per Share for the three months ended in Dec. 2024 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Bio-Works Technologies AB's Forward Dividend Yield %

For the Biotechnology subindustry, Bio-Works Technologies AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Works Technologies AB's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Works Technologies AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's Forward Dividend Yield % falls into.


;
;

Bio-Works Technologies AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Bio-Works Technologies AB  (XSAT:BIOWKS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Bio-Works Technologies AB Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Bio-Works Technologies AB's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Works Technologies AB Business Description

Traded in Other Exchanges
Address
Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Bio-Works Technologies AB Headlines

No Headlines